Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Internal Medicine Journal|April 4, 2022
Idiopathic factor V inhibitor in a patient starting haemodialysisLuke J Sutherland, Sarah Tan, Merit HannaInternal Medicine Journal|July 21, 2020
Fixed-dose three-factor prothrombin complex concentrates is safe and effective in warfarin reversalKirsty Marshall, Eileen Merriman, Merit Hanna, et al.Thrombosis and Haemostasis|November 23, 2021
Retrospective Analysis of the Effectiveness of a Reduced Dose of Idarucizumab in Dabigatran ReversalLouisa Stone, Eileen Merriman, Merit Hanna, et al.Future Science OA|July 13, 2021
A machine learning PROGRAM to identify COVID-19 and other diseases from hematology dataPatrick A Gladding, Zina Ayar, Kevin Smith, et al.Blood Advances|February 27, 2026
Phase 2 study of the lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat for essential thrombocythemiaHarinder Gill, Francesca Palandri, David M Ross, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2024
Zanubrutinib Versus Bendamustine and Rituximab in Patients With Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Median 5-Year Follow-Up of SEQUOIAMazyar Shadman, Talha Munir, Tadeusz Robak, et al.Pageof 1